Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic

Changes to donor availability, collection center capacity, and travel restrictions during the early phase of the COVID-19 pandemic led to routine cryopreservation of most unrelated donor products for hematopoietic transplantation prior to the recipient commencing the conditioning regimen. We investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Purtill, Duncan, Hutchins, Cheryl, Kennedy, Glen, McClean, Andrea, Fraser, Chris, Shaw, Peter J, Chiappini, Paul, Tao, Helen, Ma, David DF, Kabani, Karieshma, Bai, Lijun, Greenwood, Matthew, Bajel, Ashish, O'Flaherty, Elizabeth, Curtis, David J, Purins, Leanne, Perera, Travis, Tan, Sarah, Butler, Andrew, Micklethwaite, Ken, Antonenas, Vicki, Gottlieb, David, Hamad, Nada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. 2021
Materias:
Brief Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202757/
https://www.ncbi.nlm.nih.gov/pubmed/34571211
http://dx.doi.org/10.1016/j.jtct.2021.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202757/
https://www.ncbi.nlm.nih.gov/pubmed/34571211
http://dx.doi.org/10.1016/j.jtct.2021.09.012

Ejemplares similares